How Cannabis is Reshaping the Menopause Conversation | GreenState
Cannabis efficacy for menopause symptoms is gaining clinical interest as patients seek alternatives for hot flashes, mood changes, and sleep disruption. The endocannabinoid system’s role in regulating these symptoms offers a biological rationale for…
Differentiation of Cannabinoid Isomers via Cu‐Mediated Molecular Ion Formation
Cannabinoid isomer differentiation is essential for clinical safety and accurate product labeling. This study introduces a copper-mediated method to reliably distinguish cannabinoid isomers. Improved differentiation supports better clinical…
Veterans Push Congress on Cannabis & Psychedelics Access (Newsletter: March 9, 2026)
The veterans medical cannabis amendment is gaining momentum in Congress, reflecting growing advocacy for expanded access. Clinicians treating veterans must stay informed about evolving policies on cannabis and psychedelics access. This amendment could…
Emerging Role of Cannabis Compounds in Fatty Liver Disease
Emerging research shows cannabis compounds metabolic pathways may modulate metabolic-associated fatty liver disease (MASLD). This condition affects millions with limited treatment options. Understanding these pathways is crucial for clinicians monitoring…
Millions Use CBD as a Substitute for Painkillers and Medications
Millions of Americans are using CBD substitution for painkillers despite limited clinical evidence. This trend raises concerns about safety and drug interactions. Clinicians must understand these gaps to guide patient care effectively.
Study Finds Recreational Drug Use Significantly Increases Stroke Risk
A recent study highlights the recreational drug use stroke risk, including cannabis, amphetamines, and cocaine. This research emphasizes the importance of assessing cannabis cardiovascular risk during patient evaluations. Clinicians should consider…
Regulatory Digest 2026-03-09
Regulatory updates (higher clinical relevance)
Cannabis Use Disorder and Depression: A Bidirectional Link
The bidirectional relationship cannabis use disorder depression highlights the complex interplay between these conditions. Clinicians must screen for both disorders to provide integrated care. Understanding this link improves treatment outcomes for…
Is this weed?
When your patient asks if their CBD product is actually doing anything, and you realize you haven’t ordered the third-party lab results yet. The clinical uncertainty is real, and so are the unanswered questions about bioavailability. Via r/trees…
Teens’ Self-Reported Cannabis Use Linked to Increased Risk for New Psychiatric Diagnosis
This study highlights the association between adolescent cannabis use and new psychiatric diagnoses. The findings emphasize the need for screening cannabis use during adolescent mental health assessments. Understanding these risks is crucial for early…
